PAVmed Inc.
PAVM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $3 | $2 | $0 | $1 |
| % Growth | 22.1% | 550.4% | -24.6% | – |
| Cost of Goods Sold | $6 | $6 | $4 | $1 |
| Gross Profit | -$3 | -$4 | -$3 | -$0 |
| % Margin | -101.6% | -161.8% | -858.6% | -17% |
| R&D Expenses | $6 | $14 | $25 | $20 |
| G&A Expenses | $25 | $31 | $41 | $26 |
| SG&A Expenses | $36 | $49 | $61 | $34 |
| Sales & Mktg Exp. | $12 | $18 | $19 | $9 |
| Other Operating Expenses | -$1 | $2 | $2 | $0 |
| Operating Expenses | $41 | $65 | $88 | $54 |
| Operating Income | -$44 | -$69 | -$91 | -$54 |
| % Margin | -1,485.4% | -2,805.7% | -24,161% | -10,878.6% |
| Other Income/Exp. Net | $73 | -$10 | -$12 | -$2 |
| Pre-Tax Income | $28 | -$79 | -$103 | -$56 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $40 | -$64 | -$89 | -$50 |
| % Margin | 1,328.6% | -2,617.3% | -23,602.9% | -10,069.4% |
| EPS | 3.305 | -9.164 | -15.032 | -9.797 |
| % Growth | 136.1% | 39% | -53.4% | – |
| EPS Diluted | 0.496 | -9.164 | -15.032 | -9.797 |
| Weighted Avg Shares Out | 10 | 7 | 6 | 5 |
| Weighted Avg Shares Out Dil | 65 | 7 | 6 | 5 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $0 | $0 |
| Interest Expense | $0 | $1 | $1 | $0 |
| Depreciation & Amortization | $1 | $3 | $2 | $0 |
| EBITDA | $30 | -$76 | -$100 | -$56 |
| % Margin | 990.7% | -3,089% | -26,392.6% | -11,180% |